ATE477021T1 - 1,3,5-triazepin-dionen zur behandlung von malaria - Google Patents

1,3,5-triazepin-dionen zur behandlung von malaria

Info

Publication number
ATE477021T1
ATE477021T1 AT06847042T AT06847042T ATE477021T1 AT E477021 T1 ATE477021 T1 AT E477021T1 AT 06847042 T AT06847042 T AT 06847042T AT 06847042 T AT06847042 T AT 06847042T AT E477021 T1 ATE477021 T1 AT E477021T1
Authority
AT
Austria
Prior art keywords
pharmaceutically acceptable
treatment
mammal
methods
compounds
Prior art date
Application number
AT06847042T
Other languages
English (en)
Inventor
Gilles Guichard
Gersande Lena
Eliette Lallemand
Laurent Renia
Original Assignee
Immupharma France Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immupharma France Sa filed Critical Immupharma France Sa
Application granted granted Critical
Publication of ATE477021T1 publication Critical patent/ATE477021T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT06847042T 2005-12-29 2006-12-28 1,3,5-triazepin-dionen zur behandlung von malaria ATE477021T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75563205P 2005-12-29 2005-12-29
PCT/EP2006/070257 WO2007074170A2 (de) 2005-12-29 2006-12-28 Compositions and methods for the treatment and prevention of disease

Publications (1)

Publication Number Publication Date
ATE477021T1 true ATE477021T1 (de) 2010-08-15

Family

ID=37983455

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06847042T ATE477021T1 (de) 2005-12-29 2006-12-28 1,3,5-triazepin-dionen zur behandlung von malaria

Country Status (8)

Country Link
EP (1) EP1965806B1 (de)
JP (1) JP5118648B2 (de)
CN (1) CN101400352B (de)
AT (1) ATE477021T1 (de)
AU (1) AU2006331356B2 (de)
CA (1) CA2635356C (de)
DE (1) DE602006016168D1 (de)
WO (1) WO2007074170A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080031951A1 (en) 2005-12-29 2008-02-07 Gilles Guichard Compositions and methods for the inhibition of phospholipase A2
CN114436983B (zh) * 2021-11-23 2023-05-23 辽宁中医药大学 马齿苋中Oleraze和Oleraoxazine acid及其提取分离方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663333A (en) * 1992-10-22 1997-09-02 The Dupont Merck Pharmaceutical Company Substituted 1,4-diazapine caprolactams useful for treatment of HIV disease
US6452001B2 (en) * 2000-05-25 2002-09-17 Hoffmann-La Roche Inc. Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation
FR2810039B1 (fr) * 2000-06-13 2007-05-25 Centre Nat Rech Scient Composes urees cycliques et leur procede de preparation
US7001899B2 (en) * 2002-06-10 2006-02-21 The Procter & Gamble Company Interleukin converting enzyme inhibitors

Also Published As

Publication number Publication date
EP1965806B1 (de) 2010-08-11
EP1965806A2 (de) 2008-09-10
WO2007074170A3 (de) 2007-08-23
CN101400352B (zh) 2016-01-06
JP2009522235A (ja) 2009-06-11
CA2635356A1 (en) 2007-07-05
CN101400352A (zh) 2009-04-01
JP5118648B2 (ja) 2013-01-16
AU2006331356B2 (en) 2011-12-01
CA2635356C (en) 2011-11-01
WO2007074170A2 (de) 2007-07-05
AU2006331356A1 (en) 2007-07-05
DE602006016168D1 (de) 2010-09-23

Similar Documents

Publication Publication Date Title
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
DE60336664D1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
WO2005065646A3 (en) Novel drug compositions and dosage forms
TW200635582A (en) Medicaments for the treatment or prevention of fibrotic diseases
BRPI0418939A (pt) derivados de nicotinamida e sua utilização como agentes terapêuticos
WO2005063745A3 (en) Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
DE60121301D1 (de) Flibanserin zur Behandlung extrapyramidaler Bewegungsstörungen
CY1118179T1 (el) Φαρμακευτικη συνθεση
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
ATE407928T1 (de) Amino-phtalazinon derivate, anwendung als kinase inhibitoren, herstellung und pharmazeutische zusammensetzung
MY141939A (en) Pyridazine derivatives and their use as therapeutic agents
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
SE0401342D0 (sv) Therapeutic compounds
EA201270144A1 (ru) Комбинированная терапия при лечении диабета
MX2012000275A (es) Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
ECSP10010052A (es) Formulaciones galenicas de alisquireno y valsartan
WO2007046868A3 (en) Thiazolidine derivatives and their uses as therapeutic agents
WO2007046867A3 (en) Piperidine derivatives and their uses as therapeutic agents
DOP2005000039A (es) Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)- piperidin-1-il]-(4-bomo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
MXPA06007510A (es) Composiciones de farmaco y formas de dosis novedosas de topiramato.
TW200637544A (en) Medicaments for the treatment or prevention of fibrotic diseases
DE602005010744D1 (de) Piperazinylpyridinderivate als mittel gegen adipositas
WO2006125194A3 (en) Piperazine derivatives and their uses as therapeutic agents
DE60123117D1 (de) Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties